ReviewBrain communications2025
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?
Robert Durcan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it